Literature DB >> 390060

Demonstration of the complement regulating protein, beta 1H, in skin biopsies from patients with bullous pemphigoid.

J R Carlo, W R Gammon, W M Sams, S Ruddy.   

Abstract

beta 1H-globulin is a recently characterized plasma protein which regulates the biologic activities of the major fragment of the third complement component, C3b. The major function of this protein is to act as a co-factor for C3b Inactivator (C3bINA) in the cleavage of C3b to an intermediate molecule, C3b', consisting of an intact beta-chain covalently bound by disulfide bridges to 2 alpha-chain fragments of 40,000 and 67,000 daltons. Final cleavage of C3b' to the C3c and C3d fragments requires an additional protease such as plasmin or elastase. Additionally, beta 1H interferes with the activity of the alternative pathway convertases, C3bBb and C3bBbP, by displacing or competing with the binding of factor B. In this study, perilesional skin biopsies from 10 patients with active bullous pemphigoid were examined for the presence of beta 1H at the dermal-epidermal junction by immunofluorescent methods. The protein was found in 8 of 9 biopsies in which C3 also was deposited. In a single case where C3 was not found, beta 1H was not seen. These findings suggest that beta 1H plays a role in the in vivo control of C3b and provides additional evidence for the participation of the complement system in the pathogenesis of bullous pemphigoid.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 390060     DOI: 10.1111/1523-1747.ep12541572

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.

Authors:  L Borrego; B Maynard; E A Peterson; T George; L Iglesias; M S Peters; W Newman; G J Gleich; K M Leiferman
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

2.  Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.

Authors:  R E Jordon; M F Struve; L L Bushkell
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

3.  Role of different pathways of the complement cascade in experimental bullous pemphigoid.

Authors:  Kelly C Nelson; Minglang Zhao; Pamela R Schroeder; Ning Li; Rick A Wetsel; Luis A Diaz; Zhi Liu
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.